Protective effect of evolocumab on Muller cells in the rat retina under hyperglycaemic and hypoxic conditions

被引:3
作者
Zhou, Qing [1 ]
Tang, Huan [1 ]
Li, Shuting [2 ,3 ]
机构
[1] Changzhou Tradit Chinese Med Hosp, Dept Orthopaed, Changzhou 213000, Peoples R China
[2] Soochow Univ, Dept Nephrol, Affiliated Hosp 3, Changzhou 213000, Peoples R China
[3] Soochow Univ, Dept Cardiol, Affiliated Hosp 3, 185 Juqian St, Changzhou 213000, Jiangsu, Peoples R China
关键词
Diabetic retinopathy; Evolocumab; Muller cells; Inflammation; TLR-4/NF-kappa B pathway; KAPPA-B; DIABETIC-RETINOPATHY; PCSK9; INFLAMMATION; ACTIVATION; EXPRESSION; NEURODEGENERATION; ERK1/2;
D O I
10.1016/j.jdiacomp.2023.108593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: In this study, rat retinal Muller cells (RMCs) were cultured in vitro to investigate the protective mechanism of evolocumab on rat RMCs in diabetes mellitus (DM) and the expression of relevant inflammatory factors. Methods: The expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the retinal tissues of diabetic rats was detected by immunohistochemistry. Sprague-Dawley (SD) rats at 5-7 d of life were selected as the source of RMCs and divided equally into three groups of 12 rats/24 eyes each. The effect of CoCl2 and evolocumab on the cellular activity of RMCs was determined by CCK-8 assay. The effect of CoCl2 and evolocumab on the migration level of RMCs after 72 h was measured by scratch test and the expression of various proteins after 72 h was measured by Western blot. Results: In STZ rats, the expression of PCSK9 was significantly upregulated in the retina, especially in the inner nuclear layer, which is mainly composed of RMCs. High glucose and CoCl2 stimulation markedly elevated PCSK9 and GFAP expression at the protein level in RMCs (P < 0.05). Evolocumab treatment (100 mu g/ml) reduced the expression and secretion of inflammatory factors in stimulated RMCs (P < 0.05). Furthermore, evolocumab downregulates toll-like receptor-4 (TLR-4) levels and inhibited nuclear transcription factor-kappa B (NF-kappa B) phosphorylation in RMCs (P < 0.05). Conclusions: Evolocumab protects against inflammation in RMCs, at least in part, by negatively regulating the activation of the TLR-4/NF-kappa B signalling pathway. Evolocumab may be a promising anti-inflammatory therapy for ocular fundus diseases, such as DR.
引用
收藏
页数:8
相关论文
共 46 条
  • [1] PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?
    Bai, Xue-qin
    Peng, Juan
    Wang, Mei-mei
    Xiao, Jun
    Xiang, Qiong
    Ren, Zhong
    Wen, Hong-yan
    Jiang, Zhi-sheng
    Tang, Zhi-han
    Liu, Lu-shan
    [J]. CLINICA CHIMICA ACTA, 2018, 483 : 192 - 196
  • [2] Role of PCSK9 beyond liver involvement
    Cariou, Bertrand
    Si-Tayeb, Karim
    Le May, Cedric
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) : 155 - 161
  • [3] Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial
    Chen, Yundai
    Yuan, Zuyi
    Lu, Juming
    Eliaschewitz, Freddy G.
    Lorenzatti, Alberto J.
    Monsalvo, Maria Laura
    Wang, Nan
    Hamer, Andrew W.
    Ge, Junbo
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06) : 1464 - 1473
  • [4] PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
    Cheng, Jin M.
    Oemrawsingh, Rohit M.
    Garcia-Garcia, Hector M.
    Boersma, Eric
    van Geuns, Robert-Jan
    Serruys, Patrick W.
    Kardys, Isabella
    Akkerhuis, K. Martijn
    [J]. ATHEROSCLEROSIS, 2016, 248 : 117 - 122
  • [5] PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
    Ding, Zufeng
    Pothineni, Naga Venkata K.
    Goel, Akshay
    Luscher, Thomas F.
    Mehta, Jawahar L.
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 908 - 915
  • [6] Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats
    Du, YP
    Sarthy, VP
    Kern, TS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 287 (04) : R735 - R741
  • [7] DIFFERENTIAL EXPRESSION OF PCSK9 MODULATES INFECTION, INFLAMMATION, AND COAGULATION IN A MURINE MODEL OF SEPSIS
    Dwivedi, Dhruva J.
    Grin, Peter M.
    Khan, Momina
    Prat, Annik
    Zhou, Ji
    Fox-Robichaud, Alison E.
    Seidah, Nabil G.
    Liaw, Patricia C.
    [J]. SHOCK, 2016, 46 (06): : 672 - 680
  • [8] The neurovascular unit and the pathophysiologic basis of diabetic retinopathy
    Gardner, Thomas W.
    Davila, Jose R.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (01) : 1 - 6
  • [9] Tumor Necrosis Factor Alpha (TNF-α) Disrupts Kir4.1 Channel Expression Resulting in Muller Cell Dysfunction in the Retina
    Hassan, Iraj
    Luo, Qianyi
    Majumdar, Sreeparna
    Dominguez, James M., II
    Busik, Julia V.
    Bhatwadekar, Ashay D.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (05) : 3473 - 3482
  • [10] Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders
    Ibarretxe, Daiana
    Girona, Josefa
    Plana, Nuria
    Cabre, Anna
    Ferre, Raimon
    Amigo, Nuria
    Guaita, Sandra
    Mallol, Roger
    Heras, Mercedes
    Masana, Luis
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (02): : 71 - 78